Activation of the Jak3 pathway is associated with granulocytic differentiation of myeloid precursor cells

被引:24
作者
Rane, SG
Mangan, JK
Amanullah, A
Wong, BC
Vora, RK
Liebermann, DA
Hoffman, B
Graña, X
Reddy, EP
机构
[1] Temple Univ, Fels Inst Canc Res & Mol Biol, Sch Med, Philadelphia, PA 19140 USA
[2] Temple Univ, Dept Biochem, Sch Med, Philadelphia, PA 19140 USA
关键词
D O I
10.1182/blood.V100.8.2753
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Jak3, a member of the Janus kinase family of cytoplasmic tyrosine kinases, is expressed at low levels in immature hematopoietic cells and its expression is dramatically up-regulated during the terminal differentiation of these cells. To better understand the role of Jak3 in myeloid cell development, we have investigated the role of Jak3 in myeloid cell differentiation using the 32Dcl3 cell system. Our studies show that Jak3 is a primary response gene for granulocyte colony-stimulating factor (G-CSF) and the accumulation of tyrosine phosphorylated Jak3 correlated with cell growth inhibition and terminal granulocytic differentiation in response to G-CSF. Ectopic overexpression of Jak3 in 32Dcl3 cells resulted in an acceleration of the G-CSF-induced differentiation program that was preceded by G(1) cell cycle arrest, which was associated with the up-regulation of the cyclin-dependent kinase inhibitor p27(Kip1) and down-regulation of Cdk2, Cdk4, Cdk6, and Cyclin E. In addition, ectopic overexpression of Jak3 appears to result in the inactivation of PKB/Akt and Stat3-mediated proliferative pathways in the presence of G-CSF. Similarly, overexpression of Jak3 in primary bone marrow cells resulted in an acceleration of granulocytic differentiation in the presence of granulocyte-macrophage colony-stimulating factor, which was associated with their growth arrest in the G(1) phase of the cell cycle. Taken together, these results indicate that Jak3-mediated signals play an important role in myeloid cell differentiation.
引用
收藏
页码:2753 / 2762
页数:10
相关论文
共 46 条
[1]   STAT3-mediated differentiation and survival of myeloid cells in response to granulocyte colony-stimulating factor:: role for the cyclin-degendent kinase inhibitor p27Kip1 [J].
de Koning, JP ;
Soede-Bobok, AA ;
Ward, AC ;
Schelen, AM ;
Antonissen, C ;
van Leeuwen, D ;
Löwenberg, B ;
Touw, IP .
ONCOGENE, 2000, 19 (29) :3290-3298
[2]  
FLEMING TJ, 1993, J IMMUNOL, V151, P2399
[3]   AATYK: A novel tyrosine kinase induced during growth arrest and apoptosis of myeloid cells [J].
Gaozza, E ;
Baker, SJ ;
Vora, RK ;
Reddy, EP .
ONCOGENE, 1997, 15 (25) :3127-3135
[4]  
GRANA X, 1995, ONCOGENE, V11, P211
[5]   Dysregulated myelopoiesis in mice lacking Jak3 [J].
Grossman, WJ ;
Verbsky, JW ;
Yang, LP ;
Berg, LJ ;
Fields, LE ;
Chaplin, DD ;
Ratner, L .
BLOOD, 1999, 94 (03) :932-939
[6]   CORRELATION OF TERMINAL CELL-CYCLE ARREST OF SKELETAL-MUSCLE WITH INDUCTION OF P21 BY MYOD [J].
HALEVY, O ;
NOVITCH, BG ;
SPICER, DB ;
SKAPEK, SX ;
RHEE, J ;
HANNON, GJ ;
BEACH, D ;
LASSAR, AB .
SCIENCE, 1995, 267 (5200) :1018-1021
[7]  
HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.bi.60.070191.001433
[8]   STATs: Signal transducers and activators of transcription [J].
Ihle, JN .
CELL, 1996, 84 (03) :331-334
[9]  
JIANG HP, 1994, ONCOGENE, V9, P3397
[10]   PHOSPHORYLATION AND ACTIVATION OF THE JAK-3 JANUS KINASE IN RESPONSE TO INTERLEUKIN-2 [J].
JOHNSTON, JA ;
KAWAMURA, M ;
KIRKEN, RA ;
CHEN, YQ ;
BLAKE, TB ;
SHIBUYA, K ;
ORTALDO, JR ;
MCVICAR, DW ;
O'SHEA, JJ .
NATURE, 1994, 370 (6485) :151-153